Anti-sclerostin antibody, antigen binding fragment and medical use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10449250
APP PUB NO 20180099046A1
SERIAL NO

15556488

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a humanized antibody and chimeric antibody that specifically binds human sclerostin. The antibodies can be used for treating human bone metabolism related diseases such as osteoporosis (OP).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JIANGSU HENGRUI MEDICINE CO. LTD.; SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cui, Dongbing Shanghai, CN 8 17
Fu, Yayuan Shanghai, CN 13 9
Liu, Jiajian Shanghai, CN 21 227
Tao, Weikang Shanghai, CN 94 162
Wang, Yifang Shanghai, CN 7 4
Zhang, Haoying Shanghai, CN 2 1
Zhang, Lianshan Shanghai, CN 77 636
Zhang, Ling Shanghai, CN 142 622
Zhang, Zhen Shanghai, CN 434 3876

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 22, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 22, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00